Showing results (241-250 of 4,076) with videos related to
Sort By:
Pageof 408
Journal of Alzheimer'S Disease : JAD|June 24, 2010
Amyloid-beta decreases cell-surface AMPA receptors by increasing intracellular calcium and phosphorylation of GluR2Shi-Jie Liu, Robert Gasperini, Lisa Foa, et al.International Clinical Psychopharmacology|July 1, 1997
Long-term treatment of psychotic (delusional) depression with fluvoxamine: an open pilot studyR Zanardi, L Franchini, M Gasperini, et al.Neuropsychobiology|January 1, 1987
Red blood cell plasma Li ratio variability in affective patientsM Catalano, M Gasperini, A Lucca, et al.Biochimica Et Biophysica Acta|January 18, 1988
Complete release of adenosine deaminase from mouse lymphocytes stabilized by low-pH acetateS Senesi, G Freer, M Gasperini, et al.Geriatrie Et Psychologie Neuropsychiatrie Du Vieillissement|August 11, 2016
What's the hospitalisation's impact on background treatments of patients over 65 yearsGuillaume Gasperini, Sylvain Molinier, Catherine Marimoutou, et al.Journal of Affective Disorders|October 1, 1984
The search for genetic homogeneity in affective disordersE Smeraldi, A Petroccione, M Gasperini, et al.Disability and Rehabilitation. Assistive Technology|August 2, 2019
Application of upper-limb dynamic pseudoelastic splinting in the treatment of stroke chronic patient: a pilot assessmentLorenzo Garavaglia, Giulio Gasperini, Fabio Lazzari, et al.Mediators of Inflammation|January 1, 1996
Effects of copper and zinc on proteoglycan metabolism in articular cartilageM Pasqualicchio, R Gasperini, G P Velo, et al.Acta Psychiatrica Scandinavica|January 8, 1999
Mode of inheritance in mood disorder families according to fluvoxamine responseA Serretti, L Franchini, M Gasperini, et al.International Journal of Molecular Sciences|July 14, 2023
Genotoxicity Evaluation of The Novel Psychoactive Substance MTTAMonia Lenzi, Sofia Gasperini, Giorgia Corli, et al.Pageof 408